OPEN END TURBO OPTIONSSCHEIN LONG - MERCK & CO. | Market Closed - BOERSE MUENCHEN 19:26:35 28/06/2024 BST | ||
| 5.911 EUR | +2.30% |
|
| Current month | +7.43% | ||
| 1 month | +5.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 5.911 | +2.30% |
| 27/06/24 | 5.778 | -7.79% |
| 26/06/24 | 6.266 | -1.12% |
| 25/06/24 | 6.337 | +1.23% |
| 24/06/24 | 6.26 | +3.33% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 07:26 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GH7CFG |
| ISIN | DE000GH7CFG1 |
| Date issued | 04/06/2021 |
| Strike | 65.43 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.426 € |
|---|---|
| Lowest since issue | 0.92 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- Certificat
